These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24108440)

  • 21. Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.
    de Diego-Adeliño J; Portella MJ; Gómez-Ansón B; López-Moruelo O; Serra-Blasco M; Vives Y; Puigdemont D; Pérez-Egea R; Álvarez E; Pérez V
    J Psychiatry Neurosci; 2013 Mar; 38(2):107-16. PubMed ID: 23425950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.
    Kraguljac NV; Reid MA; White DM; den Hollander J; Lahti AC
    Neuropsychopharmacology; 2012 Nov; 37(12):2635-42. PubMed ID: 22805603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: A prospective 12-month proton magnetic resonance spectroscopy study.
    Silveira LE; Bond DJ; MacMillan EL; Kozicky JM; Muralidharan K; Bücker J; Rosa AR; Kapczinski F; Yatham LN
    Aust N Z J Psychiatry; 2017 Jan; 51(1):65-74. PubMed ID: 26792829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton MRS in twin pairs discordant for schizophrenia.
    Lutkenhoff ES; van Erp TG; Thomas MA; Therman S; Manninen M; Huttunen MO; Kaprio J; Lönnqvist J; O'Neill J; Cannon TD
    Mol Psychiatry; 2010 Mar; 15(3):308-18. PubMed ID: 18645571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy.
    Savic I; Thomas AM; Ke Y; Curran J; Fried I; Engel J
    Acta Neurol Scand; 2000 Sep; 102(3):179-88. PubMed ID: 10987378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
    Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure - a multimodal imaging study with PET,
    Watts JJ; Guma E; Chavez S; Tyndale RF; Ross RA; Houle S; Wilson AA; Chakravarty M; Rusjan PM; Mizrahi R
    Neuropsychopharmacology; 2022 Oct; 47(11):1984-1991. PubMed ID: 35906490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.
    Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C
    JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study.
    Keshavan MS; Dick RM; Diwadkar VA; Montrose DM; Prasad KM; Stanley JA
    Schizophr Res; 2009 Nov; 115(1):88-93. PubMed ID: 19748228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.
    Meyer EJ; Kirov II; Tal A; Davitz MS; Babb JS; Lazar M; Malaspina D; Gonen O
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2273-2279. PubMed ID: 27444940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
    Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
    Gruber O; Hasan A; Scherk H; Wobrock T; Schneider-Axmann T; Ekawardhani S; Schmitt A; Backens M; Reith W; Meyer J; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):23-31. PubMed ID: 21509595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy.
    Simister RJ; Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
    Epilepsia; 2002 Sep; 43(9):1021-31. PubMed ID: 12199727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.
    Kierans AS; Kirov II; Gonen O; Haemer G; Nisenbaum E; Babb JS; Grossman RI; Lui YW
    Neurology; 2014 Feb; 82(6):521-8. PubMed ID: 24401686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
    Moriguchi S; Takamiya A; Noda Y; Horita N; Wada M; Tsugawa S; Plitman E; Sano Y; Tarumi R; ElSalhy M; Katayama N; Ogyu K; Miyazaki T; Kishimoto T; Graff-Guerrero A; Meyer JH; Blumberger DM; Daskalakis ZJ; Mimura M; Nakajima S
    Mol Psychiatry; 2019 Jul; 24(7):952-964. PubMed ID: 30315224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
    Onwordi EC; Whitehurst T; Mansur A; Statton B; Berry A; Quinlan M; O'Regan DP; Rogdaki M; Marques TR; Rabiner EA; Gunn RN; Vernon AC; Natesan S; Howes OD
    Transl Psychiatry; 2021 Jul; 11(1):393. PubMed ID: 34282130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
    Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemical and structural correlates of executive dysfunction in schizophrenia.
    Rüsch N; Tebartz van Elst L; Valerius G; Büchert M; Thiel T; Ebert D; Hennig J; Olbrich HM
    Schizophr Res; 2008 Feb; 99(1-3):155-63. PubMed ID: 17616347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
    Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
    Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.